454 related articles for article (PubMed ID: 34522585)
1. Protease-triggered bioresponsive drug delivery for the targeted theranostics of malignancy.
Li Y; Zhang C; Li G; Deng G; Zhang H; Sun Y; An F
Acta Pharm Sin B; 2021 Aug; 11(8):2220-2242. PubMed ID: 34522585
[TBL] [Abstract][Full Text] [Related]
2. Enzyme-responsive nanoparticles for drug release and diagnostics.
de la Rica R; Aili D; Stevens MM
Adv Drug Deliv Rev; 2012 Aug; 64(11):967-78. PubMed ID: 22266127
[TBL] [Abstract][Full Text] [Related]
3. Protease-activated nanomaterials for targeted cancer theranostics.
Chan YC; Hsiao M
Nanomedicine (Lond); 2017 Sep; 12(18):2153-2159. PubMed ID: 28814163
[TBL] [Abstract][Full Text] [Related]
4. Tumor Microenvironment-Specific Functional Nanomaterials for Biomedical Applications.
Zhao L; Liu H; Xing Y; Wang R; Cheng Z; Lv C; Lv Z; Yu F
J Biomed Nanotechnol; 2020 Sep; 16(9):1325-1358. PubMed ID: 33419489
[TBL] [Abstract][Full Text] [Related]
5. Structural-Engineering Rationales of Gold Nanoparticles for Cancer Theranostics.
Chen W; Zhang S; Yu Y; Zhang H; He Q
Adv Mater; 2016 Oct; 28(39):8567-8585. PubMed ID: 27461909
[TBL] [Abstract][Full Text] [Related]
6. Chitosan-based multifunctional nanomedicines and theranostics for targeted therapy of cancer.
Fathi M; Majidi S; Zangabad PS; Barar J; Erfan-Niya H; Omidi Y
Med Res Rev; 2018 Sep; 38(6):2110-2136. PubMed ID: 29846948
[TBL] [Abstract][Full Text] [Related]
7. Self-recognizing and stimulus-responsive carrier-free metal-coordinated nanotheranostics for magnetic resonance/photoacoustic/fluorescence imaging-guided synergistic photo-chemotherapy.
Tu L; Fan Z; Zhu F; Zhang Q; Zeng S; Chen Z; Ren L; Hou Z; Ye S; Li Y
J Mater Chem B; 2020 Jul; 8(26):5667-5681. PubMed ID: 32500886
[TBL] [Abstract][Full Text] [Related]
8. Recent advances of bioresponsive polymeric nanomedicine for cancer therapy.
Hong T; Shen X; Syeda MZ; Zhang Y; Sheng H; Zhou Y; Xu J; Zhu C; Li H; Gu Z; Tang L
Nano Res; 2023; 16(2):2660-2671. PubMed ID: 36405982
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances in pH-Sensitive Polymeric Nanoparticles for Smart Drug Delivery in Cancer Therapy.
Lim EK; Chung BH; Chung SJ
Curr Drug Targets; 2018 Feb; 19(4):300-317. PubMed ID: 27262486
[TBL] [Abstract][Full Text] [Related]
10. Cancer Nanotheranostics: A Nanomedicinal Approach for Cancer Therapy and Diagnosis.
Kundu P; Singh D; Singh A; Sahoo SK
Anticancer Agents Med Chem; 2020; 20(11):1288-1299. PubMed ID: 31429694
[TBL] [Abstract][Full Text] [Related]
11. Towards tailored management of malignant brain tumors with nanotheranostics.
Aparicio-Blanco J; Torres-Suárez AI
Acta Biomater; 2018 Jun; 73():52-63. PubMed ID: 29678675
[TBL] [Abstract][Full Text] [Related]
12. "Stepwise Extraction" strategy-based injectable bioresponsive composite implant for cancer theranostics.
Yang B; Lin H; Dai C; Chen Y; Shi J
Biomaterials; 2018 Jun; 166():38-51. PubMed ID: 29533789
[TBL] [Abstract][Full Text] [Related]
13. Cancer-Targeted Nanotheranostics: Recent Advances and Perspectives.
Ma Y; Huang J; Song S; Chen H; Zhang Z
Small; 2016 Sep; 12(36):4936-4954. PubMed ID: 27150247
[TBL] [Abstract][Full Text] [Related]
14. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional two-dimensional nanocomposites for photothermal-based combined cancer therapy.
Wang X; Cheng L
Nanoscale; 2019 Aug; 11(34):15685-15708. PubMed ID: 31355405
[TBL] [Abstract][Full Text] [Related]
16. Application of nanotechnology to target and exploit tumour associated proteases.
Cogo F; Williams R; Burden RE; Scott CJ
Biochimie; 2019 Nov; 166():112-131. PubMed ID: 31029743
[TBL] [Abstract][Full Text] [Related]
17. Application of modelling and nanotechnology-based approaches: The emergence of breakthroughs in theranostics of central nervous system disorders.
Hassanzadeh P; Atyabi F; Dinarvand R
Life Sci; 2017 Aug; 182():93-103. PubMed ID: 28583367
[TBL] [Abstract][Full Text] [Related]
18. Emerging advances in cancer nanotheranostics with graphene nanocomposites: opportunities and challenges.
Rahman M; Akhter S; Ahmad MZ; Ahmad J; Addo RT; Ahmad FJ; Pichon C
Nanomedicine (Lond); 2015; 10(15):2405-22. PubMed ID: 26252175
[TBL] [Abstract][Full Text] [Related]
19. Theranostic nanomedicine.
Lammers T; Aime S; Hennink WE; Storm G; Kiessling F
Acc Chem Res; 2011 Oct; 44(10):1029-38. PubMed ID: 21545096
[TBL] [Abstract][Full Text] [Related]
20. Recent advances of redox-responsive nanoplatforms for tumor theranostics.
Chen M; Liu D; Liu F; Wu Y; Peng X; Song F
J Control Release; 2021 Apr; 332():269-284. PubMed ID: 33662455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
